Nobuo Fukuda

Okinawa Protein Tomography Ltd. provides polymeric molecular structure analysis services. Its technology allows imaging of macromolecules including proteins in multiple states at the single molecule-level by combining conventional electron tomography and a specifically designed 3D reconstruction program known as COMET. The firm analyzes data of molecular structures of protein samples. The company was founded by Akira Kamei on June 25, 2014 and is headquartered in Uruma, Japan.

Ai-BrainScience, Inc. is a company founded in 2019 and based in Osaka, Japan. The Japanese company specializes in developing medical devices using the "aitracking type cognitive function evaluation method" to find early detection of dementia and achieve early intervention. The company's website provides a technical introduction to their cognitive function evaluation method and their business investment opportunities.

Bio-Sight Capital, Inc. (Bio-Sight Capital) is an independent venture capital firm headquartered in Osaka, Japan with a branch office in Kanagawa prefecture. The firm was founded in 2002.